MEDIFAST INC Quarterly Cost of Revenue in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Medifast Inc quarterly/annual Cost of Revenue history and growth rate from Q2 2010 to Q4 2024.
  • Medifast Inc Cost of Revenue for the quarter ending December 31, 2024 was $30.8M, a 38% decline year-over-year.
  • Medifast Inc Cost of Revenue for the twelve months ending December 31, 2024 was $158M, a 46.7% decline year-over-year.
  • Medifast Inc annual Cost of Revenue for 2024 was $158M, a 46.7% decline from 2023.
  • Medifast Inc annual Cost of Revenue for 2023 was $296M, a 35.4% decline from 2022.
  • Medifast Inc annual Cost of Revenue for 2022 was $458M, a 15% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $158M $30.8M -$18.9M -38% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-18
Q3 2024 $177M $34.5M -$24M -41% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $201M $45.1M -$40.4M -47.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $241M $47.4M -$55.1M -53.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $296M $49.6M -$54M -52.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-18
Q3 2023 $350M $58.5M -$49.1M -45.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $399M $85.5M -$46.2M -35.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $445M $103M -$12.7M -11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $458M $104M +$4.1M +4.12% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-18
Q3 2022 $454M $108M +$1.21M +1.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $453M $132M +$31.2M +31% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $422M $115M +$23.2M +25.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-01
Q4 2021 $398M $99.5M +$33.9M +51.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $365M $106M +$38.9M +57.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $326M $100M +$39.8M +65.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $286M $92.1M +$48.9M +113% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $237M $65.7M +$23.1M +54.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-21
Q3 2020 $214M $67.4M +$20.3M +43.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $194M $60.7M +$14.3M +30.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $179M $43.2M +$2.49M +6.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $177M $42.6M +$5.81M +15.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $171M $47.1M +$15.1M +47.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 $156M $46.4M +$17.9M +62.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $138M $40.7M +$16.9M +71.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $121M $36.8M +$17.9M +94.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $103M $32M +$13M +68.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $90.2M $28.5M +$10.4M +57.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $79.8M $23.8M +$6.06M +34.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $73.8M $18.9M +$3.5M +22.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $70.3M $19M +$2.61M +15.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $67.6M $18.1M +$199K +1.11% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $67.4M $17.7M -$1.42M -7.42% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $68.9M $15.4M -$709K -4.41% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $69.6M $16.4M -$361K -2.15% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $69.9M $17.9M -$1.08M -5.66% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $71M $19.2M -$443K -2.26% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $71.5M $16.1M -$1.23M -7.12% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $72.7M $16.8M -$1.51M -8.24% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $74.2M $19M -$164K -0.86% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $74.4M $19.6M -$1.72M -8.05% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $76.1M $17.3M +$3.24M +23% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $72.8M $18.3M -$3.34M -15.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $76.2M $19.2M -$4.98M -20.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $81.2M $21.3M -$2.33M -9.84% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $83.5M $14.1M -$345K -2.39% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $83.8M $21.6M -$1.01M -4.44% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $84.8M $24.1M +$711K +3.03% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $84.1M $23.6M +$1.47M +6.61% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $82.7M $14.4M -$2.81M -16.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $85.5M $22.6M +$3.01M +15.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $82.5M $23.4M +$4.22M +21.9% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $78.2M $22.2M +$4.56M +25.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $73.7M $17.2M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 $19.6M +$2.8M +16.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $19.2M +$2.02M +11.7% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $17.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 $16.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $17.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.